Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Nov 2018 04:00 PM
RNS
Directorate Change
19 Nov 2018 01:02 PM
RNS
PERSERIS(TM) Availability
16 Nov 2018 03:52 PM
RNS
Director Declaration
13 Nov 2018 04:22 PM
RNS
Holding(s) in Company
09 Nov 2018 03:00 PM
RNS
Block listing Interim Review
06 Nov 2018 02:37 PM
RNS
Holding(s) in Company
06 Nov 2018 07:00 AM
RNS
Indivior Announces Upcoming Investor Events
01 Nov 2018 11:01 AM
RNS
3rd Quarter Results
01 Nov 2018 07:00 AM
RNS
Total Voting Rights
31 Oct 2018 01:12 PM
RNS
Holding(s) in Company
30 Oct 2018 08:53 AM
RNS
Holding(s) in Company
25 Oct 2018 07:00 AM
RNS
Indivior Applauds New U.S. Opioid Legislation
23 Oct 2018 03:55 PM
RNS
Holding(s) in Company
17 Oct 2018 07:00 AM
RNS
Notice of Results
05 Oct 2018 04:04 PM
RNS
Holding(s) in Company
28 Sep 2018 04:29 PM
RNS
Holding(s) in Company
26 Sep 2018 04:41 PM
RNS
Second Price Monitoring Extn
26 Sep 2018 04:35 PM
RNS
Price Monitoring Extension
26 Sep 2018 04:19 PM
RNS
Indivior Provides Business Update
20 Sep 2018 03:50 PM
RNS
Holding(s) in Company
19 Sep 2018 03:35 PM
RNS
Director Declaration
12 Sep 2018 07:00 AM
RNS
Indivior unable to attend Investor Conference
10 Sep 2018 07:00 AM
RNS
Indivior Prepays $150 Million of Outstanding Debt
04 Sep 2018 07:00 AM
RNS
Morgan Stanley Annual Global Healthcare Conference
21 Aug 2018 04:37 PM
RNS
Holding(s) in Company
10 Aug 2018 03:38 PM
RNS
Holding(s) in Company
06 Aug 2018 04:19 PM
RNS
Holding(s) in Company
01 Aug 2018 07:00 AM
RNS
Total Voting Rights
31 Jul 2018 07:00 AM
RNS
Indivior Preliminary Injunction Upheld
30 Jul 2018 07:01 AM
RNS
DRL's Appeal of Indivior's PI Granted-in-Part
30 Jul 2018 07:00 AM
RNS
US FDA Approves Indivor's PERSERIS(TM)
27 Jul 2018 08:40 AM
RNS
Holding(s) in Company
26 Jul 2018 09:01 AM
RNS
Holding(s) in Company
25 Jul 2018 07:00 AM
RNS
Half-year Report
24 Jul 2018 07:00 AM
RNS
Holding(s) in Company
16 Jul 2018 07:00 AM
RNS
US Court Grants Indivior Preliminary Injunction
13 Jul 2018 04:39 PM
RNS
Holding(s) in Company
12 Jul 2018 05:16 PM
RNS
Holding(s) in Company
11 Jul 2018 07:00 AM
RNS
Indivior Sees FY18 Guidance Below Expectations
10 Jul 2018 07:00 AM
RNS
Notice of Results
03 Jul 2018 07:01 AM
RNS
Holding(s) in Company
03 Jul 2018 07:00 AM
RNS
Holding(s) in Company
29 Jun 2018 07:00 AM
RNS
Indivior's Temporary Restraining Order is Extended
21 Jun 2018 02:56 PM
RNS
Holding(s) in Company
20 Jun 2018 07:00 AM
RNS
Holding(s) in Company
18 Jun 2018 07:00 AM
RNS
Indivior Is Granted Temporary Restraining Order
15 Jun 2018 03:56 PM
RNS
Holding(s) in Company
15 Jun 2018 01:59 PM
RNS
Indivior Responds to Generic SUBOXONE ® Approvals
07 Jun 2018 09:30 AM
RNS
Holding(s) in Company
01 Jun 2018 07:00 AM
RNS
Total Voting Rights

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100